Global·EN  
中文 English 日本語

Reliable source for a strong supply chain

For more than 20 years, Fengrui has collaborated with a network of high-quality manufacturers. Its product range includes APIs, fine chemicals,plant extracts, FDFs, supplements，biopharmaceuticals and more, catering to the diverse needs of various customers. This collaboration has allowed Fengrui to develop significant advantages in cost control, product quality, customization, and delivery speed and flexibility. The goal is to help customers distinguish themselves in a competitive market and achieve their business objectives.

More
  • 500+Chinese Manufacturers
  • 70+Supplement Factories
  • 80+Fine Chemicals Factories
  • 70%GMP qualified
  • 260+API Factories
  • 30+Excipient Factories
  • 20+Biopharmaceuticals Factories
  • 40+Plant Extract Factories

Products&Services

APIs

Fengrui is dedicated to providing customers with high-quality, safe, and reliable APIs. Our suppliers of APIs encompass nearly all common drugs to fulfill our customers' needs.

Fine Chemicals

We offer a diverse range of fine chemical products across various fields. Our exceptional quality and stability have earned the trust of our customers. Many of our suppliers have established a strong reputation among global clients due to their advanced production techniques, rigorous quality management systems, and excellent after-sales services.

Plant Extracts

Our partners in plant extraction are dedicated to transforming nature's valuable resources into high-quality and effective health solutions.

FDFs

We have established extensive cooperation on formulation products with various pharmaceutical enterprises and medical institutions. Our formulation supply partners enforce strict quality control and stability testing, providing customized solutions tailored to different customer needs.

Supplements

We offer our customers high-quality and high-performance nutraceutical product solutions. We carefully select suppliers who meet high standards. From the procurement of raw materials to production and processing, and through to testing, we aim for excellence at every stage to meet the strict requirements of our nutraceutical product customers.

BiopharmaceuticalS

We are dedicated to supplying high-quality and diverse biopharmaceuticals that meet the production needs of pharmaceutical companies worldwide. By implementing a rigorous supplier screening and quality control system, we ensure that our biopharmaceuticals comply with all relevant international and domestic regulations and standards.

CDMO

Fengrui has been actively involved in the pharmaceutical industry supply chain for over 20 years. We have developed strong capabilities in pharmaceutical research and development services and can offer customized product research and development solutions tailored to meet our customers' needs.

About Fengrui

An Expert Caretaker in Pharma Supply Chain

Fengrui company was established in 2002 and has spent the past two decades deeply integrated into the pharmaceutical industry. The company has built a high-quality supply chain for global pharmaceutical clients, which includes APIs, fine chemicals, plant extracts, FDFs, supplements, biopharmaceuticals. Fengrui provides comprehensive supply chain management services, covering everything from research and development to trade for both domestic and international clients. More than 70% of the team at Fengrui has a professional background in chemical pharmacy, giving them extensive experience in the global pharmaceutical business. They have developed a complete and mature service model and process, allowing them to quickly and accurately understand the needs of overseas customers. With a strong network of supplier resources and in-depth knowledge of drug regulations, Fengrui helps clients efficiently find high-quality suppliers that meet their specific requirements. Additionally, through the in-depth development of numerous projects with clients, the company aids Chinese suppliers in understanding advanced pharmaceutical concepts and provides support for their entry into overseas markets.

More

News Center

More